Conversely, miR-454-3p was also observed to act as a tumor suppressor in bladder cancer (30) and non–small cell lung cancer (31) by targeting the EMT inducer ZEB2 or constituent Ca2+-binding protein calbindin 1 (CALB1), respectively. This evidence concerns the gene ZEB2 and urinary bladder cancer.